The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT

Annette Juul Vangsted, T. W. Klausen, W. Ruminski, Peter Gimsing, N.F. Andersen, O.A. Gang, Niels Abildgaard, L.M. Knudsen, J.L. Nielsen, H. Gregersen, Ulla Vogel

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    OriginalsprogEngelsk
    TidsskriftBone Marrow Transplantation
    Vol/bind43
    Udgave nummer7
    Sider (fra-til)539-545
    ISSN0268-3369
    DOI
    StatusUdgivet - 2009

    Citer dette

    Vangsted, A. J., Klausen, T. W., Ruminski, W., Gimsing, P., Andersen, N. F., Gang, O. A., Abildgaard, N., Knudsen, L. M., Nielsen, J. L., Gregersen, H., & Vogel, U. (2009). The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT. Bone Marrow Transplantation, 43(7), 539-545. https://doi.org/10.1038/bmt.2008.351